Pluristem Therapeutics Inc., of Haifa, Israel, was issued Australian patent No. 2008300185, “Methods for Cell Expansion and Uses of Cells and Conditioned Media Produced thereby for Therapy,” which covers the use of adherent placental cells for the treatment of ischemia, a restriction of blood supply to tissues, and for treatments of conditions that require connective tissue repair or regeneration.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter